Nifty 500 Healthcare: relative strength and momentum
Sector. Compared with Nifty 500 TRI.
As of 2026-10-23, Nifty 500 Healthcare has an ArthaNiti relative-strength score of 74 out of 100 (strong) against Nifty 500 TRI, in the Lead fading phase (still gaining, but the lead is shrinking); the score moved -10 points in four weeks. Returns use Official TRI (net of TER).
1 week−2.3%
1 month−9.1%
3 months−6.5%
6 months+5.1%
1 year+4.5%
3 years, a year+18.8%
5 years, a year+12.7%
Volatility, 1 year13.2%
Worst fall, 1 year−9.6%
Above 200-day averageYes
What is inside Nifty 500 Healthcare: holdings and weights
Nifty 500 Healthcare holds 44 stocks; the top 10 make up 60% of the index. 48% of its stocks trade above their 200-day average.
- 21 of 44 stocks (48%) are above their 200-day average — narrow participation.
- Short-term breadth (7% above 50-day) is fading faster than long-term — momentum is cooling.
- Top 10 stocks are 60% of the index; half the weight sits in 8 stocks.
- Biggest 1-month driver: Dr. Reddy's Laboratories Ltd. (+1.5%).
| Stock | Industry | Weight | 3 months | Momentum score |
|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Ltd. | Healthcare | 10.14% | −10.5% | 61 |
| DIVISLAB Divi's Laboratories Ltd. | Healthcare | 8.76% | +22.5% | 92 |
| APOLLOHOSP Apollo Hospitals Enterprise Ltd. | Healthcare | 6.23% | −12.8% | 55 |
| LAURUSLABS Laurus Labs Ltd. | Healthcare | 5.72% | +25.6% | 98 |
| CIPLA Cipla Ltd. | Healthcare | 5.62% | −4.0% | 58 |
| DRREDDY Dr. Reddy's Laboratories Ltd. | Healthcare | 5.58% | +5.4% | 67 |
| TORNTPHARM Torrent Pharmaceuticals Ltd. | Healthcare | 5.24% | −10.7% | 70 |
| MAXHEALTH Max Healthcare Institute Ltd. | Healthcare | 5.13% | −24.8% | 22 |
| LUPIN Lupin Ltd. | Healthcare | 3.66% | −19.5% | 37 |
| AUROPHARMA Aurobindo Pharma Ltd. | Healthcare | 3.43% | +3.2% | 79 |
ETFs that track Nifty 500 Healthcare
| ETF | NSE symbol | Expense ratio | Tracking diff, 1 yr | AUM |
|---|---|---|---|---|
| Mirae Asset Nifty 500 Healthcare ETF | HEALTHCARE | 0.35% | – | ₹15 Cr |
ArthaNiti publishes market data and analytics for education. It is not investment advice or a research recommendation, and ArthaNiti is not registered with SEBI as an Investment Adviser or Research Analyst.